Alight, Inc. / Delaware 8-K

What Happened

• Alight, Inc. announced it received a written notice from the New York Stock Exchange on March 24, 2026, saying the company was not in compliance with Section 802.01C because the average closing price of its Class A common stock was under $1.00 over a consecutive 30 trading-day period ending March 20, 2026.
• The Company said the notice does not affect ongoing business operations or its SEC reporting and has no immediate impact on the listing so long as other listing standards remain met. Alight responded that it is committed to curing the deficiency and is considering actions, including a possible reverse stock split subject to stockholder approval no later than its next annual meeting. The company issued a press release about the notice on March 27, 2026.

Key Details

• Notice received: March 24, 2026; triggering period ended March 20, 2026 (30 trading days).
• Minimum share price requirement: $1.00 per share under NYSE Section 802.01C.
• Cure period: Six months from receipt of the notice to regain compliance.
• Potential cure actions: May regain compliance if closing price on the last trading day of any month in the cure period is ≥ $1.00 and the 30-trading-day average ending that day is ≥ $1.00; company is considering a reverse stock split (would require shareholder approval).

Why It Matters

• If Alight fails to meet the $1.00 threshold by the end of the six-month cure period, the NYSE could delist the stock, which would reduce liquidity and make trading more difficult for investors.
• A reverse stock split, if approved, would reduce the number of outstanding shares and likely increase the per-share price, but would not change the company’s market value by itself and would require a shareholder vote.
• Investors should monitor Alight’s daily/30-day share price trends and any shareholder meeting notices or management updates about a reverse split or other actions to regain compliance.